Skip to main content

Advertisement

SpringerLink
Log in

Optic neuritis associated with sunitinib

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Hartmann JT, Haap M, Kopp HG, Lipp HP (2009) Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effects. Curr Drug Metab 10(5):470–481. https://doi.org/10.2174/138920009788897975

    Article  CAS  PubMed  Google Scholar 

  2. Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR (1979) An algorithm for the operational assessment of adverse drug reactions: I. Background, description, and instructions for use. Jama 242(7):623–632

    Article  CAS  Google Scholar 

  3. Maharaj AS, Walshe TE, Saint-Geniez M, Venkatesha S, Maldonado AE, Himes NC, Matharu KS, Karumanchi SA, D'Amore PA (2008) VEGF and TGF-β are required for the maintenance of the choroid plexus and ependyma. J Exp Med 205(2):491–501

    Article  CAS  Google Scholar 

  4. Aparicio-Gallego G, Blanco M, Figueroa A, García-Campelo R, Valladares-Ayerbes M, Grande-Pulido E, Antón-Aparicio L (2011) New insights into molecular mechanisms of sunitinib-associated side effects. Mol Cancer Ther 10(12):2215–2223

    Article  CAS  Google Scholar 

  5. Kanaan Z, Kulairi Z, Titianu M, Saha S, Kumar S (2014) Guillain-Barré syndrome following treatment with sunitinib malate. Case Rep Oncol Med 2014:1–2

    Google Scholar 

  6. Watanabe O, Maruyama I, Arimura K, Kitajima I, Arimura H, Hanatani M, Matsuo K, Arisato T, Osame M (1998) Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow–Fukase (POEMS) syndrome. Muscle Nerve 21(11):1390–1397

    Article  CAS  Google Scholar 

  7. Babu KG, Attili VSS, Bapsy P, Anupama G (2007) Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia. Int Ophthalmol 27(1):43–44

    Article  Google Scholar 

  8. Deschamps ME, Provencal J (2012) Une névrite optique toxique induite par le sunitinib. Oncologie 14(12):679–681. https://doi.org/10.1007/s10269-012-2148-7

    Article  Google Scholar 

  9. Monge KS, Gálvez-Ruiz A, Alvárez-Carrón A, Quijada C, Matheu A (2015) Optic neuropathy secondary to dasatinib in the treatment of a chronic myeloid leukemia case. Saudi J Ophthalmol 29(3):227–231

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, College of Medicine, Incheon St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea

    Seunghee Na & Taewon Kim

Authors
  1. Seunghee Na
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Taewon Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SN wrote the manuscript. TK supervised the project.

Corresponding author

Correspondence to Taewon Kim.

Ethics declarations

Conflict of interest

None.

Ethical approval

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Na, S., Kim, T. Optic neuritis associated with sunitinib. Neurol Sci 42, 1165–1167 (2021). https://doi.org/10.1007/s10072-020-04713-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04713-x

Search

Navigation